# OnCo record nct06700603 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06700603/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06700603", "NCT06700603" ;
  schema:name "Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer"@en ;
  schema:description "A phase 2 trial of fluorouracil (5-FU) in pancreatic cancer, run by Rui-hua Xu, MD, PhD, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06700603/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06700603> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "pancreatic-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/fluorouracil/> .